Scientists are developing and testing a new vaccine intended to help the immune system detect and eliminate early signs of colon cancer before tumors form. The approach is designed to “intercept” cancer at a stage earlier than conventional treatment, by training immune responses against specific cancer-related changes that can occur in the colon. The reporting indicates that initial testing is now underway, with researchers evaluating how the vaccine performs and whether it can prevent disease progression rather than only treating established cancer.
Tests begin for vaccine aimed at preventing early colon cancer
Scientists are developing and testing a new vaccine intended to help the immune system detect and eliminate early signs of colon cancer before tumors form. The approach is designed to “intercept” canc...
- Researchers are developing a colon-cancer vaccine designed to target early-stage disease.
- The vaccine is intended to train the immune system to intercept cancer before tumors develop.
- Testing of the vaccine is underway.
- The goal is prevention or interruption of cancer progression, rather than treatment after full tumor formation.
- The reporting describes the work as an early-stage effort involving clinical or preclinical evaluation.
Scientists are creating a new kind of vaccine that teaches the immune system to intercept a type of brewing colon cancer before it turns into a full-fledged tumor
4 hours ago
TikTok creator Sydney Towle dies at 26 after battle with cholangiocarcinoma
Sydney Towle, a TikTok creator with more than 1.1 million followers, dies at age 26 after a prolonged battle with a rare...
Glanbia raises full-year forecasts on protein demand and stronger first-half performance
Glanbia says it is increasing its full-year earnings forecast after reporting a strong first half and citing continued m...
FDA approves Moderna’s first mRNA seasonal flu vaccine for adults 50 and older
The U.S. Food and Drug Administration (FDA) approves mFlusiva (mRNA flu vaccine), the first licensed influenza shot made...